THIADIAZOLE DERIVATIVES AS INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF
摘要:
The present disclosure relates to compounds of Formula (I): (I) or a pharmaceutically acceptable salt thereof, wherein Ring A, R1, R2, R3, R4, and m are described herein, methods of preparation, methods of treatment, and pharmaceutical compositions comprising same. The present disclosure further relates to the use of the compounds of Formula (I), and pharmaceutically acceptable salts thereof, in the treatment of cGAS-related diseases and disorders.
[EN] ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH<br/>[FR] AGENTS ANTIPROLIFÉRATIFS POUR LE TRAITEMENT DE L'HTAP
申请人:PFIZER
公开号:WO2020212865A1
公开(公告)日:2020-10-22
This invention relates to compounds of general Formula I in which A, R1, R2, R3 and R4 are as defined herein, and the pharmaceutically acceptable salts thereof; to pharmaceutical compositions comprising such compounds and salts; to methods of using such compounds, salts and compositions for treating pulmonary hypertension and related diseases, like pulmonary arterial hypertension; to methods of using such compounds, salts and compositions for treating abnormal cell growth, such as cancer; and to processes to make such compounds, salts and compositions.
important quaternary α-benzyl- and α-allyl-α-methylamino cyclobutanones in good to high yield, via a sequential one-pot methylation/sigmatropic rearrangement, has been accomplished for the first time. The quaternary α-alkyl-α-amino cyclobutanones could be further manipulated, affording synthetically interesting scaffolds such as highlysubstituted tryptamines and cyclobuta-fused indolines.
This invention relates to compounds of general Formula I
in which A, R1, R2, R3 and R4 are as defined herein, and the pharmaceutically acceptable salts thereof; to pharmaceutical compositions comprising such compounds and salts; to methods of using such compounds, salts and compositions for treating pulmonary hypertension and related diseases, like pulmonary arterial hypertension; to methods of using such compounds, salts and compositions for treating abnormal cell growth, such as cancer; and to processes to make such compounds, salts and compositions.
本发明涉及通式 I 的化合物
其中 A、R1、R2、R3 和 R4 如本文所定义,及其药学上可接受的盐;涉及包含此类化合物和盐的药物组合物;涉及使用此类化合物、盐和组合物治疗肺动脉高压及相关疾病(如肺动脉高压)的方法;涉及使用此类化合物、盐和组合物治疗异常细胞生长(如癌症)的方法;以及涉及制造此类化合物、盐和组合物的工艺。
SUZUKI TAKAYOSHI; TAKAMOTO MASAYUKI; OKAMOTO TOSHIHIKO; TAKAYAMA HIROAKI, CHEM. AND PHARM. BULL., 34,(1986) N 5, 1888-1900